After a strong first half year, Roche has raised its revenue guidance for 2018 and now expects sales to grow by a mid-single digit figure. Revenue in the first half was CHF 28.1 billion ($28.3 billion), up by 7% from a year earlier measured in both Swiss francs and in constant exchange rates.
Revenue for the second quarter was CHF 14.5 billion, also up by 7%.